CA-NEXON-AMERICA-INC.
28.4.2022 01:21:05 CEST | Business Wire | Press release
MapleStory , the original free-to-play, side scrolling 2D MMORPG from Nexon , has announced that the latest update in celebration of the game’s 17th Anniversary, Blooming Forest, is now live. The update brings an overabundance of nature to the forest of Arcana and the spirits are inviting Maplers to come spend some time amongst the flowers, trees, rocks - and even the weeds!
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220427006183/en/
The MapleStory story is one of longevity in a time when games come to market in a flash – and are gone just as fast. Launched globally in 2005, the unique 2D side-scrolling MMORPG with an aggressively cute game style, earned MapleStory legions of fans, known as Maplers, and a player base that longs for a hit of nostalgia. Now, in its seventeenth year, MapleStory continues to grow, offering new, exciting challenges and rewarding adventures to Maplers of all ages.
And, to celebrate MapleStory’s 17th Anniversary, the spirits have brought special events to the Blooming Forest! Maplers can earn Blooming Coins from various activities during the events, which can then be used at the Blooming Communal Coin Shop and the Blooming Personal Coin Shop for valuable enhancement and cosmetic items.
There are many ways for Maplers to spend quality time in the Arcana forest by participating in themed events and missions, including:
- Blossoming Flowers (April 27 to June 14): Help the Blooming Flowers in Blooming Forest by giving them sunshine and obtaining rewards and Blooming Skill Points each time they bloom! Blooming Skill Points can be used to enhance Maplers’ passive stats.
- Floral Blessing (April 27 to June 14): Scatter flower seeds so beautiful flowers can bloom everywhere in spring. When accepting the quest, Maplers will acquire the Floral Blessing Skill, which will provide perks and bonuses. Strengthen Floral Blessing Skill by leveling it up and, in turn, it will provide Maplers with additional Blooming Coins.
- Blooming Race (April 27 to May 24): Charge through the map, avoiding various obstacles over five stages of the race, earning Blooming Coins based on the last stage cleared.
- Legion Gardening (April 27 to June 14): Give a helping hand and remove weeds for the flowers of the Blooming Forest to blossom! Players with Legion level over 500 (cumulative total of all of your character’s levels) will continue removing weeds regardless of login status.
-
Blooming Moment
(April 27 to June 14): The sunlight and wind of Blooming Forest are very special! Enter Blooming Forest Meadow map every 30-minute mark of each hour to receive either Warm Spring Sunlight
or Cool Spring Wind
buff. Cool Spring Wind will be active every odd-number hours, while Warm Spring Sunlight will be active every even-number hours. Warm Spring Sunlight and Cool Spring Wind buffs will stack with other similar buff effects.
- Warm Spring Sunlight : Grants EXP +15% for 30 minutes
- Cool Spring Wind : Grants STR/DEX/INT/LUK +15, Weapon ATT / Magic ATT +15, Enemy Defense Ignored +15%, Boss Damage +15%, MaxHP/MaxMP +1,500 for 30 minutes
Don’t leave the gardens of the Arcana forest untended! Heaps of fun and bountiful rewards await MapleStory players in the Blooming Forest.
Assets: HERE
Social Media: Twitch / Facebook / Twitter / YouTube / Website
About MapleStory https://maplestory.nexon.net
MapleStory is one of the largest and most active free-to-play, side-scrolling MMORPGs with over 13 million registered players from its Global services alone out of a total seven MapleStory services around the world. First released in North America in May 2005, the game continues to grow and evolve alongside its passionate community since launching over 17 years ago. There have been over 274 million characters created to date, which would make MapleStory ’s Maple World the 4th highest populated country in the world.
About Nexon America Inc. https://www.nexon.com/
Founded in 2005, Nexon America Inc. delivers outstanding free-to-play online game expertise and live game support, taking the strengths of NEXON Co., Ltd. (“Nexon”) and applying them for uniquely western audiences. Nexon America has consistently sustained iconic franchises such as MapleStory and Mabinogi for more than a decade, which have gone on to break records and captivate players. With new projects on the horizon, Nexon America maintains the pioneering and innovative spirit of its parent company, employing its player-first approach, while designing the best possible gameplay experiences for the western market.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220427006183/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Kubota Vision Inc. Signs Supply and Licensing Agreement with Laboratoires KÔL for Stargardt Disease Treatment Candidate Under Compassionate Use4.5.2026 17:16:00 CEST | Press release
Kubota Vision Inc. (“Kubota Vision”), a wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Minato-ku, Tokyo, Japan) announced signing of a Supply and Licensing Agreement with Laboratoires KÔL (Clermont-Ferrand, France) for the provision of a Stargardt disease (STGD1) treatment candidate under compassionate use authorization. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260414590785/en/ The purpose of this Agreement is for Kubota Vision and KÔL to collaborate on providing “Emixustat” for treatment of Stargardt Disease (STGD1) through compassionate use authorization in France. Kubota Vision will exclusively manufacture and supply Emixustat final products to KÔL and KÔL will have exclusive rights to distribute Emixustat in France under compassionate use access. Ryo Kubota, Chairman, President, and CEO of Kubota Pharmaceutical Holdings, stated, “We are extremely pleased to enter into this Agreement with Labor
Incentive Market Set to Surpass $80B by 2030s — IMA Launches Tools to Help the Industry Keep Pace4.5.2026 16:28:00 CEST | Press release
With combined business spend on loyalty, employee recognition, and channel incentives projected to exceed $80 billion by the 2030s, the incentive industry is entering a period of rapid scale and strategic pressure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260422729016/en/ In response, the Incentive Marketing Association (IMA) launched a new suite of resources designed to help incentive professionals navigate an environment that’s becoming more specialized, fragmented, and central to business performance. “It’s not just more money coming in—it’s more complexity,” said Vince Chiofolo, President of the Incentive & Engagement Solution Providers (IESP). “Buyers are demanding programs that evolve fast, integrate deeply, and feel personal at scale. These new tools were built for that.” IMA’s Suite of Tools Includes: New Industry Report — Inside the Incentive Buyer’s Mind Drawn from insights of 50+ program owners, the report f
Tigo Energy Breaks Global Growth Benchmark; Boosts U.S. Energy Feature in Predict+4.5.2026 15:00:00 CEST | Press release
Advanced energy prediction platform adds real-time energy pricing for North American Independent System Operator (ISO) customers, accelerates meters-connected growth. Tigo Energy, Inc. (NASDAQ: TYGO) (“Tigo” or “Company”), a leading provider of intelligent solar and energy solutions, today announced that the Predict+ platform now offers integrated real-time spot market pricing for ISO customers in the United States. Predict+ provides utilities with deep insights into grid demand, renewable generation, and energy market dynamics, enhancing the precision, scalability, and robustness of energy forecasting to up to 97.5% accuracy through machine learning and artificial intelligence. For energy providers, Predict+ helps streamline operations, reduce volatility, and maximize performance. Predict+ empowers utility operators to adapt to real-world demand challenges when balancing renewable and baseload generation sources, particularly during extreme weather events and market disruptions. On th
Airship Announces 2026 Elevate Customer Experience Award Winners4.5.2026 15:00:00 CEST | Press release
Southwest Airlines, The Economist, and OneFootball among brands recognized at Elevate’26 Customer Experience Summit for setting the standard in mobile-first and AI-centered customer experiences Airship, the mobile-first customer experience company, today announced the winners of the 2026 Elevate Customer Experience Awards. Global brand leaders from The Economist, Southwest Airlines, and OneFootball were among those honored at the Elevate’26 Customer Experience Summit. The Elevate Awards spotlight global companies that have developed exceptional mobile-first customer experiences for their customers, created innovative campaigns, leveraged AI agents to reach new levels of productivity, and achieved real business results. "Evolving mobile-first consumer behaviors and unprecedented advancements in AI are driving a seismic shift that is reshaping how brands interact with their customers," said Brett Caine, CEO, Airship. "The 2026 Elevate Award winners aren’t just adapting, they’re leading t
Alnylam to Present New Analyses at Heart Failure 2026 Underscoring Consistent Clinical Profile of Vutrisiran in ATTR-CM4.5.2026 14:30:00 CEST | Press release
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced it will present new data analyses for vutrisiran in patients with the cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) at Heart Failure 2026, a scientific congress of the European Society of Cardiology, taking place May 9-12, 2026, in Barcelona, Spain. ATTR-CM is a heterogeneous and rapidly progressive disease, and patients often present with complex clinical profiles. At Heart Failure 2026, Alnylam will present multiple new analyses from the Phase 3 HELIOS-B study of vutrisiran, which continue to support its use as a first-line treatment for patients with ATTR-CM, and further characterize its clinical profile across patients with a high disease burden, and in the context of concomitant therapies. Vutrisiran is the first and only transthyretin (TTR) silencer for ATTR-CM that delivers rapid knockdown of TTR at the source. Additional analyses being pr
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
